Every SEC Form 3/4/5 on record for this filer (CIK 1660683) — 39 issuers, 83 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
This filer is an entity, not a person. This reporting owner's name carries a corporate/fund legal form, so it is an ENTITY filing under Section 16 — typically a fund with a board-designation right or a 10% holder — not an individual. Its 'director' rows are the entity's designation right, not a person's board seat.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | Director | 2020-08-25 → 2026-06-26 | 20 | $24M |
| OLMA | Olema Pharmaceuticals, Inc. | Director | 2020-11-19 → 2026-06-23 | 12 | $16M |
| MLTX | MoonLake Immunotherapeutics | Director | 2022-04-15 → 2026-06-22 | 7 | — |
| XOMA | XOMA Royalty Corp | Filer | 2017-02-21 → 2026-05-18 | 31 | $6M |
| IMUX | IMMUNIC, INC. | Director | 2026-02-27 → 2026-02-27 | 1 | — |
| RPTX | Repare Therapeutics Inc. | Filer | 2021-11-08 → 2026-01-30 | 8 | $9M |
| EPIX | ESSA Pharma Inc. | Filer | 2022-07-21 → 2025-10-14 | 3 | — |
| CBIO | CRESCENT BIOPHARMA, INC. | Filer | 2025-06-17 → 2025-06-17 | 1 | — |
| ALLK | Allakos Inc. | Filer | 2024-01-26 → 2025-05-19 | 2 | — |
| PVLA | PALVELLA THERAPEUTICS, INC. | Filer | 2024-12-17 → 2024-12-17 | 1 | — |
| FDMT | 4D Molecular Therapeutics, Inc. | Filer | 2022-06-27 → 2024-11-13 | 3 | — |
| ELDN | Eledon Pharmaceuticals, Inc. | Filer | 2022-01-31 → 2024-10-31 | 4 | — |
| THRD | Third Harmonic Bio, Inc. | Filer | 2022-12-22 → 2024-10-31 | 3 | — |
| RAIN | Rain Enhancement Technologies Holdco, Inc. | Director · lapsed | 2021-04-27 → 2024-01-29 | 12 | $2M |
| PNT | POINT Biopharma Global Inc. | Filer · lapsed | 2023-11-06 → 2023-12-20 | 2 | — |
| ENGN | enGene Therapeutics Inc. | Filer · lapsed | 2023-11-13 → 2023-11-13 | 1 | — |
| CTIC | CTI BIOPHARMA CORP | Director · lapsed | 2015-12-14 → 2023-06-28 | 11 | $1M |
| PIRS | PIERIS PHARMACEUTICALS, INC. | Filer · lapsed | 2018-11-26 → 2023-05-22 | 5 | — |
| GPCR | Structure Therapeutics Inc. | Filer · lapsed | 2023-02-13 → 2023-05-12 | 2 | — |
| CGEM | Cullinan Therapeutics, Inc. | Filer · lapsed | 2022-01-10 → 2023-01-19 | 5 | — |
| VSTM | Verastem, Inc. | Filer · lapsed | 2022-02-07 → 2022-02-07 | 1 | — |
| MRUS | Merus N.V. | Filer · lapsed | 2020-01-13 → 2021-10-08 | 15 | $5M |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Filer · lapsed | 2019-10-02 → 2021-03-08 | 14 | $3M |
| INFI | INFINITY PHARMACEUTICALS, INC. | Filer · lapsed | 2016-12-02 → 2021-02-19 | 15 | $2M |
| CTMX | CytomX Therapeutics, Inc. | Filer · lapsed | 2020-12-28 → 2021-02-18 | 2 | — |
| IDYA | IDEAYA Biosciences, Inc. | Filer · lapsed | 2020-06-22 → 2021-02-04 | 4 | — |
| NVUS | Eledon Pharmaceuticals, Inc. | Filer · lapsed | 2020-10-05 → 2020-12-28 | 2 | — |
| CYTK | CYTOKINETICS INC | Filer · lapsed | 2019-12-12 → 2020-12-11 | 7 | −$5M |
| GLYC | GLYCOMIMETICS INC | Filer · lapsed | 2017-05-11 → 2020-11-06 | 5 | — |
| PRNB | Principia Biopharma Inc. | Filer · lapsed | 2020-08-20 → 2020-08-20 | 2 | — |
| CALA | Calithera Biosciences, Inc. | Filer · lapsed | 2019-07-01 → 2020-05-26 | 5 | — |
| CNCE | CONCERT PHARMACEUTICALS, INC. | Filer · lapsed | 2017-09-29 → 2019-06-12 | 5 | — |
| IMDZ | IMMUNE DESIGN CORP. | Filer · lapsed | 2018-11-09 → 2018-12-04 | 2 | −$2M |
| SNDX | Syndax Pharmaceuticals Inc | Filer · lapsed | 2017-12-08 → 2018-06-20 | 2 | — |
| ARQL | ARQULE INC | Filer · lapsed | 2017-10-20 → 2018-06-01 | 4 | −$5M |
| XENE | Xenon Pharmaceuticals Inc. | Filer · lapsed | 2016-09-12 → 2018-03-29 | 8 | — |
| RGLS | Regulus Therapeutics Inc. | Filer · lapsed | 2017-11-27 → 2017-11-27 | 1 | — |
| NVLS | Nivalis Therapeutics, Inc. | Filer · lapsed | 2017-05-11 → 2017-06-22 | 6 | — |
| ONTY | Cascadian Therapeutics, Inc. | 10% owner · lapsed | 2015-12-22 → 2016-06-27 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| KYMR | 2025-06-30 | Buy | 142,604 | $44.00 | $6M | 2,798,795 |
| KYMR | 2025-06-30 | Buy | 115,783 | $44.00 | $5M | 2,219,858 |
| KYMR | 2025-06-30 | Buy | 58,780 | $44.00 | $3M | 353,412 |
| RPTX | 2023-11-16 | Buy | 153,693 | $5.38 | $826,868 | 5,309,432 |
| RPTX | 2023-11-16 | Buy | 125,909 | $5.38 | $677,390 | 4,308,573 |
| RPTX | 2023-11-16 | Buy | 16,143 | $5.38 | $86,849 | 548,938 |
| RPTX | 2023-11-15 | Buy | 47,712 | $5.00 | $238,560 | 532,795 |
| RPTX | 2023-11-15 | Buy | 493,337 | $5.00 | $2M | 5,155,739 |
| RPTX | 2023-11-15 | Buy | 390,507 | $5.00 | $2M | 4,182,664 |
| RPTX | 2023-11-02 | Buy | 218,979 | $3.60 | $788,324 | 4,662,402 |
19 of 39 issuers are covered and open a security page; the rest are on file here only.
